Markteintritt von Biosimilars in Deutschland: Adalimumab-Fallstudie – Ausschreibungen, Krankenhäuser & Akzeptanz August 28, 2025 Pharma & Biotech, Tech Biosimilar market entry in Germany for adalimumab is shaped by tendering, hospital procurement, and regional policies driving uptake and cost-savings. Continue Reading
